Beschreibung:
<jats:title>Abstract</jats:title><jats:p>The effects of glucocorticoids and corticotrophin‐releasing factor (CRF) on the release of various molecular forms of adrenocorticotrophic hormone (ACTH) have been investigated in primary cultures of rat anterior pituitary. The rat cells responded to a 30 min challenge with CRF by secreting increased amounts of ACTH, as assessed both by bioassay, using rat adrenocortical cells, and by radioimmunoassay. Inclusion of a synthetic glucocorticoid, such as dexamethasone (DEX), in the incubation for 5 min prior to, and during the CRF challenge, had no effect on the response as measured by radioimmunoassay. Bioassay, however, indicated profound suppression of the response to CRF. This discrepancy between ACTH immuno‐ and bioactivity was investigated by fractionating the immunoreactive ACTH species using high‐performance liquid chromatography. The lower molecular weight (<15kd) forms (ACTH<jats:sub>1–39</jats:sub>, phosphorylated ACTH<jats:sub>1–39</jats:sub> and glycosylated ACTH<jats:sub>1±39</jats:sub>) were separated from higher molecular weight (>15kd) forms (i.e. ACTH biosynthetic intermediate and proopiomelanocortin) using C‐18 Sep‐Pak. The lower molecular weight molecules were further resolved into glycosylated and non‐glycosylated ACTH, using an acetonitrile gradient high‐performance liquid chromatography with trifluoroacetic acid as an ion‐pairer. Neither the proportion of low molecular weight forms of ACTH, nor that of glycosylated ACTH<jats:sub>1–39</jats:sub> secreted in response to CRF, were affected by DEX. Further fractionation of non‐glycosylated ACTH, also using acetonitrile gradient high‐performance liquid chromatography but with heptafluorobutyric acid as the ion‐pairer, yielded peaks corresponding to phosphorylated and non‐phosphorylated ACTH<jats:sub>1–39</jats:sub>. DEX significantly increased the proportion of phosphorylated ACTH secreted in response to CRF by 18%. An additional effect of DEX was revealed when Sep‐Pak extracts were treated with alkaline phosphatase, prior to analysis. After dephosphorylation, it became clear that the peptides released by CRF‐stimulated cells were different if DEX was present in the medium. The peptide released in the presence of DEX (ACTH‐S) had a slightly, but consistently, different retention time on high‐performance liquid chromatography and very little biological activity. Antibody cross‐reactivity studies suggested that ACTH‐S was modified in the 1–24 region of the peptide. It is concluded that challenge of anterior pituitary cells in primary culture with CRF, following 5 min previous exposure to DEX, results in a molecular change. The consequence of this is that ACTH immunoreactivity is released, but the molecule has reduced biological activity. This may be part of the mechanism by which fast feedback inhibition of ACTH secretion is effected.</jats:p>